This piece originally ran in Health Affairs on Oct. 26, 2025.

For more than 40 years, I have advocated against policies that discriminate against people with disabilities and other vulnerable populations. ​

In this week's edition...
 
— Health Affairs: PIPC Chairman Highlights PDAB Shortcomings. Click here to view the article. 
— TODAY: NMQF Patient-Centered Physical Laws Framework (PLF) and MFN. Register to join here.
— ICER Again Fails to Address Patient and Disability Concerns Related to its Biased Methodology. View PIPC’s Data Mine blog related to the methodology and protocol here.
— PIPC Response to Trump Administration’s Continued Push for MFN Pricing. Click here to view the statement.
— Pharmaphorum Discusses the Affordability of Medicines and Innovation. Click here to read the article.
— PIPC Chairman Explains that the MFN is Exacting Too High a Price for Patients and People with Disabilities. Click here to read the statement.
— SFS Releases Survey Results Detailing Americans' Rejection of Foreign Drug Pricing Schemes. See details below.
— Data Mine Blog Analyzes a New Study from OHE on International Reference to QALYs. See details below.
— Reps. Cammack and Hern Introduce QALY Ban Bill. See details below.
— Opportunity: Sign an Open Letter Rejecting Use of QALYs and Similar Measures. See details below.
— Update on the Texas v. Kennedy Lawsuit. See details below.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.

In this week's edition...
 
— Health Affairs: Sisters Working It Out Highlights PDAB Shortcomings. Click here to view the article. 
— POLITICO: Britain prepares NHS drug spending hike to stave off Trump tariffs. Click here to view the article.
— PIPC Response to Trump Administration’s Continued Push for MFN Pricing. Click here to view the statement.
— Pharmaphorum Discusses the Affordability of Medicines and Innovation. Click here to read the article.
— Engaging Medicaid Members and Community-Based Organizations Through Beneficiary Advisory Councils. Click here to learn more.
— PIPC Chairman Explains that the MFN is Exacting Too High a Price for Patients and People with Disabilities. Click here to read the statement.
— Thyroid Foundation Hosts Webinar on Patient Access. Click here to RSVP.
— SFS Releases Survey Results Detailing Americans' Rejection of Foreign Drug Pricing Schemes. See details below.
— Data Mine Blog Analyzes a New Study from OHE on International Reference to QALYs. See details below.
— Reps. Cammack and Hern Introduce QALY Ban Bill. See details below.
— Opportunity: Sign an Open Letter Rejecting Use of QALYs and Similar Measures. See details below.
— Update on the Texas v. Kennedy Lawsuit. See details below.
— Learn More About Alternative Measures for Value Assessment. Click here to learn more.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.

In this week's edition...
 
— PIPC Response to Trump Administration’s Continued Push for MFN Pricing. Click here to view the statement.
— Pharmaphorum Discusses the Affordability of Medicines and Innovation. Click here to read the article.
— Engaging Medicaid Members and Community-Based Organizations Through Beneficiary Advisory Councils. Click here to learn more.
— PIPC Chairman Explains that the MFN is Exacting Too High a Price for Patients and People with Disabilities. Click here to read the statement.
— Thyroid Foundation Hosts Webinar on Patient Access. Click here to RSVP.
— SFS Releases Survey Results Detailing Americans' Rejection of Foreign Drug Pricing Schemes. See details below.
— Data Mine Blog Analyzes a New Study from OHE on International Reference to QALYs. See details below.
— Reps. Cammack and Hern Introduce QALY Ban Bill. See details below.
— Opportunity: Sign an Open Letter Rejecting Use of QALYs and Similar Measures. See details below.
— Update on the Texas v. Kennedy Lawsuit. See details below.
— Learn More About Alternative Measures for Value Assessment. Click here to learn more.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.

The Partnership to Improve Patient Care (PIPC) has issued the following statement in response to the Trump administration's consideration of "Most Favored Nations" policy in the U.S.

In this week's edition...
 
— PIPC Response to Trump Administration’s Continued Push for MFN Pricing. Click here to view the statement.
— Engaging Medicaid Members and Community-Based Organizations Through Beneficiary Advisory Councils. Click here to learn more.
— PIPC Chairman Explains that the MFN is Exacting Too High a Price for Patients and People with Disabilities. Click here to read the statement.
— SFS Releases Survey Results Detailing Americans' Rejection of Foreign Drug Pricing Schemes. See details below.
— Bonnell Foundation in Detroit News: Critique of MFN as an Avenue for Drug Pricing Reform. Click here to read the article.
— Patient Organizations Send Letter to Washington PDAB. See details below.
— ICHOM Working Group: Kidney Stones Set Feedback Opportunity. See details below.
— PIPC Comment to CMS on ICR Emphasizes QALY Transparency. See details below.
— PIPC Urges Minnesota PDAB to Reject Discriminatory Value Assessments. Click here to read the letter.
— CMS Referenced QALYs in Explanations for Medicare Drug Price Negotiation Program. See details below.
— EACH/PIC Releases Results from Patient-Led Survey on Drug Affordability. See details below.
— Data Mine Blog Analyzes a New Study from OHE on International Reference to QALYs. See details below.
— Reps. Cammack and Hern Introduce QALY Ban Bill. See details below.
— Opportunity: Sign an Open Letter Rejecting Use of QALYs and Similar Measures. See details below.
— National Minority Quality Forum Issue Brief Details MFN Consequences. Click here to read the issue brief.
— Update on the Texas v. Kennedy Lawsuit. See details below.
— Learn More About Alternative Measures for Value Assessment. Click here to learn more.
— Emerging Threats in States for Use of Discriminatory Metrics. See details below.
— What Happens in Countries Using QALYs and Cost-Based Thresholds? See details below.
— ICER's QALY-Based Study Topics. See details below.
— Upcoming Events and Webinars. See details below.